Correlation Between Summit Materials and GW Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Summit Materials and GW Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Materials and GW Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Materials and GW Pharmaceuticals Plc, you can compare the effects of market volatilities on Summit Materials and GW Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Materials with a short position of GW Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Materials and GW Pharmaceuticals.

Diversification Opportunities for Summit Materials and GW Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Summit and GWPH is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Summit Materials and GW Pharmaceuticals Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GW Pharmaceuticals Plc and Summit Materials is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Materials are associated (or correlated) with GW Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GW Pharmaceuticals Plc has no effect on the direction of Summit Materials i.e., Summit Materials and GW Pharmaceuticals go up and down completely randomly.

Pair Corralation between Summit Materials and GW Pharmaceuticals

If you would invest (100.00) in GW Pharmaceuticals Plc on February 4, 2024 and sell it today you would earn a total of  100.00  from holding GW Pharmaceuticals Plc or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Summit Materials  vs.  GW Pharmaceuticals Plc

 Performance 
       Timeline  
Summit Materials 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Materials are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Summit Materials may actually be approaching a critical reversion point that can send shares even higher in June 2024.
GW Pharmaceuticals Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GW Pharmaceuticals Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, GW Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Summit Materials and GW Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Summit Materials and GW Pharmaceuticals

The main advantage of trading using opposite Summit Materials and GW Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Materials position performs unexpectedly, GW Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GW Pharmaceuticals will offset losses from the drop in GW Pharmaceuticals' long position.
The idea behind Summit Materials and GW Pharmaceuticals Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device